Breathe Well Live Well
|
Prostaglandin D2 receptor antagonist fails against asthma
ModernMedicine A product of activated mast cells, prostaglandin D2 reportedly mediates asthmatic responses through D-prostanoid (DP) and chemoattractant receptor homologous molecule expressed on TH2 cells (CRTH2), both of which are blocked by AMG 853. Dr. William … |
View full post on asthma – Google News
|
MediciNova shares plunge as asthma drug fails in Ph IIb trial
The Pharma Letter MediciNova intends to design pivotal trial(s) that will include technological and operational improvements and further controls for medications that are not typically used in the treatment of acute exacerbations of asthma and were over-represented in … |
View full post on asthma – Google News
|
MediciNova shares crash after lead asthma drug fails IIb trial
FierceBiotech MediciNova's ($MNOV) shares crashed after the San Diego-based biotech said its Phase IIb study of an acute asthma drug failed to hit the primary endpoint. And while the CEO tried to put the data in context, offering reasons for optimism for a planned … MediciNova asthma drug fails trial; shares crash MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma … |
View full post on asthma – Google News
|
MediciNova asthma drug fails trial; shares crash
Reuters (Reuters) – Biopharmaceutical company MediciNova Inc said its experimental asthma drug failed to meet the main goal of a second mid-stage trial, sending its shares down as much as 51 percent in extended trade. MediciNova, which is testing MN-221 as a … MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma … MediciNova (MNOV) Says Results of Phase 2B Trial of MN-221 Didn't Meet Primary … |
View full post on asthma – Google News
|
Targacept says drug candidate worked as an asthma treatment, but fails as …
Greenfield Daily Reporter AP WINSTON-SALEM, NC — Shares of Targacept Inc. declined Tuesday after the company said its drug candidate TC-6987 worked as a treatment for asthma in a clinical trial, but failed as a treatment for diabetes. Targacept said asthma patients who were … Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of … Asthma drug shows promise, diabetes study fails in Targacept phase 2 trials Targacept reports mixed data from two trials |
View full post on asthma – Google News
|
Targacept says drug candidate worked as an asthma treatment, but fails as …
The Republic AP WINSTON-SALEM, NC — Shares of Targacept Inc. declined Tuesday after the company said its drug candidate TC-6987 worked as a treatment for asthma in a clinical trial, but failed as a treatment for diabetes. Targacept said asthma patients who were … Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of … Asthma drug shows promise, diabetes study fails in Targacept phase 2 trials Targacept reports mixed data from two trials |
View full post on asthma – Google News
|
Prevacid Fails to Control Asthma
dailyRx Using Prevacid (Lansoprazole) may not be effective in helping to treat poorly managed asthma in children. In a new study, children whose asthma was poorly controlled with inhaled corticosteroids did not benefit from using a acid reflex medication. |
View full post on asthma – Google News
 Visit Bulgaria |
Theravance Falls Most in 3 Years After Glaxo Drug Fails
BusinessWeek The company, based in South San Francisco, California, said in a statement today that Relovair, its drug for asthma and chronic obstructive pulmonary disease, proved no better than Glaxo's Seretide in a clinical trial. Relovair is “the most important … GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies … Glaxo on the slide after trials setback for asthma drug Theravance Shares Slide on Lung Drug Deaths |
View full post on asthma – Google News
|
Asthma breathalyser defence fails
Daily Gleaner By Craig Babstock A Bathurst judge recently rejected a man's claim that asthma prevented him from providing a breath sample to a police officer who smelled alcohol on his breath. Provincial court Judge Steven Hutchinson presided over the breathalyser … |
View full post on asthma – Google News
 TakePart |
Rand Paul Fails Asthma Science
TakePart Rand Paul's dubious claim is bad news for the 25 million asthma sufferers in the United States. (Photo: Getty Images) With so many things in the country unraveling right now, it must be hard for a libertarian like Rand Paul to select just … |
View full post on asthma – Google News